Anthony J. Cesare, Makoto T. Hayashi, Laure Crabbe, Jan Karlseder 

Slides:



Advertisements
Similar presentations
Figure S1 A MRC5 Control Chk1 TdR(h): γH2AX Cleaved casp3 RPA34
Advertisements

Volume 14, Issue 2, Pages (August 2008)
Volume 14, Issue 4, Pages (May 2004)
María Dolores Vázquez-Novelle, Mark Petronczki  Current Biology 
Volume 53, Issue 4, Pages (February 2014)
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis  Motofumi.
Volume 34, Issue 4, Pages (August 2015)
Volume 27, Issue 4, Pages (August 2007)
Volume 35, Issue 3, Pages (August 2009)
Telomere-Driven Tetraploidization Occurs in Human Cells Undergoing Crisis and Promotes Transformation of Mouse Cells  Teresa Davoli, Titia de Lange  Cancer.
Volume 55, Issue 1, Pages (July 2014)
Volume 30, Issue 1, Pages (April 2008)
Volume 44, Issue 4, Pages (November 2011)
Volume 44, Issue 3, Pages (November 2011)
DNA Degradation at Unprotected Telomeres in Yeast Is Regulated by the CDK1 (Cdc28/Clb) Cell-Cycle Kinase  Momchil D. Vodenicharov, Raymund J. Wellinger 
Volume 35, Issue 2, Pages (July 2009)
Volume 1, Issue 6, Pages (December 2001)
Condensin Is Required for Nonhistone Protein Assembly and Structural Integrity of Vertebrate Mitotic Chromosomes  Damien F. Hudson, Paola Vagnarelli,
Volume 45, Issue 4, Pages (February 2012)
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase  Rémi Buisson, Jessica L. Boisvert, Cyril H. Benes,
Volume 46, Issue 2, Pages (April 2012)
Volume 22, Issue 1, Pages (January 2012)
Volume 53, Issue 6, Pages (March 2014)
Volume 63, Issue 2, Pages (July 2016)
Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age- Related Phenotypes through Telomerase Manipulation  Elsa Vera, Nazario.
Cdk1 Modulation Ensures the Coordination of Cell-Cycle Events during the Switch from Meiotic Prophase to Mitosis  Dai Tsuchiya, Soni Lacefield  Current.
Volume 17, Issue 4, Pages (February 2007)
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
SMARCAL1 Resolves Replication Stress at ALT Telomeres
Volume 7, Issue 4, Pages (May 2014)
Volume 47, Issue 3, Pages (August 2012)
Volume 130, Issue 5, Pages (September 2007)
Volume 35, Issue 3, Pages (August 2009)
Telomere Protection by TPP1/POT1 Requires Tethering to TIN2
Volume 13, Issue 1, Pages (January 2008)
TRF2 Protects Human Telomeres from End-to-End Fusions
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 69, Issue 5, Pages e5 (March 2018)
Raymond L. Warters, Patrick J. Adamson, Christopher D. Pond, Sancy A
Volume 2, Issue 6, Pages (December 2012)
Ramiro E. Verdun, Laure Crabbe, Candy Haggblom, Jan Karlseder 
Volume 55, Issue 1, Pages (July 2014)
Volume 17, Issue 22, Pages (November 2007)
Volume 48, Issue 5, Pages (December 2012)
Volume 15, Issue 6, Pages (September 2004)
Volume 19, Issue 5, Pages (September 2005)
Telomere-Driven Tetraploidization Occurs in Human Cells Undergoing Crisis and Promotes Transformation of Mouse Cells  Teresa Davoli, Titia de Lange  Cancer.
Volume 31, Issue 1, Pages (July 2008)
Histone–GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells  Teru Kanda, Kevin F. Sullivan, Geoffrey M. Wahl 
Volume 33, Issue 5, Pages (March 2009)
Richard W. Deibler, Marc W. Kirschner  Molecular Cell 
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Volume 47, Issue 4, Pages (August 2012)
DNA Damage Foci at Dysfunctional Telomeres
Cdc18 Enforces Long-Term Maintenance of the S Phase Checkpoint by Anchoring the Rad3-Rad26 Complex to Chromatin  Damien Hermand, Paul Nurse  Molecular.
Lindsey A. Allan, Paul R. Clarke  Molecular Cell 
Volume 18, Issue 12, Pages (December 2010)
Volume 52, Issue 2, Pages (October 2013)
Christopher Bruhn, Zhong-Wei Zhou, Haiyan Ai, Zhao-Qi Wang 
Volume 17, Issue 6, Pages (November 2016)
Peng Wu, Megan van Overbeek, Sean Rooney, Titia de Lange 
Volume 27, Issue 4, Pages (August 2007)
Volume 14, Issue 2, Pages (August 2008)
Volume 3, Issue 3, Pages (March 1999)
Volume 9, Issue 3, Pages (November 2014)
Bradley A. Stohr, Lifeng Xu, Elizabeth H. Blackburn  Molecular Cell 
Cdk1 Modulation Ensures the Coordination of Cell-Cycle Events during the Switch from Meiotic Prophase to Mitosis  Dai Tsuchiya, Soni Lacefield  Current.
by Omesha N. Perera, Alexander P. Sobinoff, Erdahl T
Fig. 5 hTERT promotion of Hsp70-1 telomere localization is dependent on Apollo and assists the telomere protective function of Apollo. hTERT promotion.
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

The Telomere Deprotection Response Is Functionally Distinct from the Genomic DNA Damage Response  Anthony J. Cesare, Makoto T. Hayashi, Laure Crabbe, Jan Karlseder  Molecular Cell  Volume 51, Issue 2, Pages 141-155 (July 2013) DOI: 10.1016/j.molcel.2013.06.006 Copyright © 2013 Elsevier Inc. Terms and Conditions

Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Induction of Intermediate- and Uncapped-State Telomeres (A) Timeline of the experiments in (B–K). (B) Western blots of whole-cell extracts from the indicated cultures. (C) Fluorescent micrographs of IMR90 E6E7 cells. Interphase nuclei were stained with DAPI, telomere fluorescence in situ hybridization (FISH), and γ-H2AX and 53BP1 immunofluorescence (IF) and imaged in four colors. A single interphase nucleus is shown with γ-H2AX IF presented above and 53BP1 IF below. The bar is equivalent to 10 μm. Metaphase-TIF (meta-TIF) assays were stained with DAPI, telomere FISH, and γ-H2AX IF. Cytogenetic preparations were stained with telomere FISH and propidium iodide (PI). (D) Quantitation of γ-H2AX-associated telomeres in meta-TIF assays and telomere fusions in cytogenetic preparations (mean ± SD; n = 3). (E) Western blots of whole-cell extracts from IMR90 E6E7 cultures with or without TRF2 overexpression (pWZL-TRF2) and shRNA transduction. (F) Quantitation of meta-TIF assays and cytogenetic preparations (mean ± range; n = 2; p = two-tailed t test) on the cells shown in (E). (G) TRF2 ChIP of HT1080 6TG cells transduced with the indicated shRNAs. (H) Quantitation of the ChIP assay shown in (G) (mean ± range; n = 2). (I) Quantitation of meta-TIF assays on AT22IJET AT-cells with and without ATM complementation (mean ± SD; n = 3; p = two-tailed t test). Western blots of whole-cell extracts from the indicated cell cultures are shown below. (J) Comparison of γ-H2AX IF signal at exposed chromosome ends and internal fusions from meta-TIF assays of TRF2 sh-G cells (mean ± SD; n = 3 experiments of >130 fusions). (K) Images of telomere fusions lacking γ-H2AX IF staining. See also Figures S1 and S2. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 TRF2 Depletion Does Not Activate the G2/M Checkpoint in HT1080 6TG Cells (A) Timeline of the experiments in (B–E). (B) Examples of meta-TIF assays and cytogenetic preparations (cyto) from HT1080 6TG cells. Meta-TIF assays were stained with DAPI, γ-H2AX IF, and telomere FISH, and the cytogenetic preparations were stained with PI and telomere FISH. (C) Quantitation of meta-TIF assays and cytogenetic preparations (mean ± range; n = 2) depicted in (B). (D) Cell-cycle profiles of HT1080 6TG cultures following control or TRF2 sh transduction. A representative experiment quantifying ≥15,000 cells per condition is shown. (E) Western blots on whole-cell extracts prepared from HT1080 6TG cultures. The control shRNA sample is from 7 days posttransduction, and the 1 Gy IR sample is parental cells that recovered for 1 hr before sample collection. (F) Western blots on whole-cell extracts from untreated or irradiated HT1080 6TG cultures with or without shRNA at 7 days posttransduction. Irradiated cultures recovered for 1 hr before sample collection. (G) Cell-cycle profiles of untreated or irradiated HT1080 6TG cells with or without shRNA at 7 days posttransduction. A representative experiment quantifying ≥15,000 cells per condition is shown. (H) Quantitation of H3-S10-positive cells in untreated or irradiated HT1080 6TG cultures with or without shRNA at 7 days posttransduction (mean ± SD; n = 3 experiments quantifying ≥25,000 cells per condition). See also Figure S3. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Deprotected Telomeres Are Passed On between Cell-Cycle Phases and Through Cell Division (A) shRNA-transduced IMR90 E6E7 cultures were synchronized with a double thymidine block so that the cultures were 7 days posttransduction at release. Following release, cells were collected every 2 hr for analysis by flow cytometry and fluorescent imaging. Cell-cycle profiles represent ≥10,000 cells per condition. Cells were stained for imaging with DAPI, telomere FISH, and γ-H2AX and 53BP1 IF and imaged in four colors. One nucleus is shown for each condition, with γ-H2AX IF presented above and 53BP1 IF below. (B) A representative HT1080 6TG TRF2 sh-G anaphase cell stained with DAPI, telomere FISH, and γ-H2AX and 53BP1 IF. The white bar in (A) and (B) is equivalent to 10 μm. (C) Quantitation of γ-H2AX-stained telomere chromatids in meta-TIF assays on asynchronous cultures transduced with the indicated shRNAs. Individual metaphases are represented by a dot, the population average by a black bar, and the percentage of metaphases with ≥20 γ-H2AX(+) telomere chromatids indicated (mean ± SD; n = 3). (D) HT1080 6TG cells with or without shRNA transduction were treated with the indicated dose of IR, allowed to recover for 1 hr, and the number of H3-S10(+) cells was determined by flow cytometry. Data are shown as the percentage of H3-S10(+) cells relative to the no-IR control (mean ± SE; n = 3 experiments of 50,000 cells per condition). See also Figure S4 and Movies S1, S2, S3, and S4. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Differential Signaling from Intermediate-State Telomeres Induces p53-Dependent G1 Phase Growth Arrest (A) Timeline of the experiments in (B–H). (B) Four-color imaging of IMR90 cells with or without shRNA transduction stained with DAPI, telomere FISH, and γ-H2AX and 53BP1 IF. A single nucleus is shown for each condition, with γ-H2AX IF above and 53BP1 IF below. (C) Quantitation of interphase-TIF as shown in (B) (mean ± SD; n = 3 experiments with typically ≥100 nuclei quantified). (D) Western blots of whole-cell extracts from untreated or shRNA-transduced IMR90 cells. The 1 Gy IR-treated sample is parental cells that recovered for 1 hr before collection. (E) Growth curves of untreated or shRNA-transduced IMR90 cells from days 6–10 posttransduction (mean ± SD; n = 3). (F) Flow cytometry determined cell-cycle distribution of untreated or shRNA-transduced IMR90 cells at 7 days posttransduction (mean ± SD; n = 3 experiments quantifying ≥10,000 cells per condition). (G) Micrograph of an interphase chromatin bridge in IMR90 E6E7 TRF2 sh-G. The white bar in (B) and (G) is equivalent to 10 μm. (H) Quantitation of internuclear bridges in IMR90 and IMR90 E6E7 cultures at 7 days posttransduction (mean ± SD; n = 3 experiments quantifying ≥500 nuclei). (I) Western blots of parental IMR90 cells treated with varying doses of IR that recovered for 1 hr before sample collection. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Intermediate-State Telomeres Are Passed Through Mitosis to Arrest Growth in G1 Phase (A) Timeline of the experiments in (B–D). (B) Western blots on whole-cell extracts from IMR90 cultures. The control sh sample is 7 days posttransduction, and the 1 Gy IR sample is parental cells that recovered for 1 hr after IR before collection. (C) Cell-cycle profiles of control sh or TRF2 sh-G-transduced IMR90 cells at days 3–7 posttransduction (representative experiment quantifying ≥10,000 cells per condition). (D) Graphical representation of the data in (C) (mean ± SD; n = 3). (E) Fluorescent micrographs of adherent mitotic cells in asynchronous culture (top) or meta-TIF assays (bottom) from control sh and TRF2 sh-G-transduced IMR90 cultures at day 3.5 posttransduction. Adherent cells were stained with DAPI, telomere FISH, and γ-H2AX IF, and H3-S10 IF and Meta-TIF assays were stained with DAPI, telomere FISH, and γ-H2AX IF. (F) Quantitation of the meta-TIF assays shown in (E). Each metaphase is represented by a dot and the population average with a black bar, and the percentage of metaphases with ≥10 and ≥20 γ-H2AX-assocaited telomere chromatids is indicated (mean ± SD; n = 3). Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 The Telomere-Dependent Prolonged Mitotic Arrest Checkpoint Signals Through Intermediate-State Telomeres (A) Timeline of the experiments performed in IMR90 cells without shRNA transduction in (B and C). (B) Meta-TIF assays performed on IMR90 cultures treated as shown in (A). Samples were stained with DAPI, γ-H2AX IF, and TRF2 IF. (C) Western blots on whole-cell extracts from IMR90 cultures treated as shown in (A). (D) Timeline of the experiments on control sh or TRF2 sh-F-transduced IMR90 E6E7 cells shown in (E–G). Cells were 7 days posttransduction when released from the double thymidine block. (E) Quantitation of meta-TIF assay experiments in IMR90 E6E7 control shRNA and TRF2 sh-F cells as shown in Figure S5 (mean ± SD; n = 3). Cells were treated as shown in (D) and Figure S5. (F) Quantitation of fused chromosome ends in cytogenetic preparations following 36 hr of recovery after shake-off isolation of IMR90 E6E7 control shRNA or TRF2 sh-F cells undergoing a prolonged mitotic arrest (mean ± range; n ≥ 2). Cells were treated as shown in (D) without Hesperadin or DMSO treatment 10 hr after release. (G) Western blots of whole-cell extracts prepared from IMR90 E6E7 control shRNA or TRF2 sh-F cells following prolonged mitotic arrest. Cells were treated as shown in (D) without Hesperadin or DMSO treatment 10 hr after release. Irradiated cultures recovered for 1 hr before sample collection. See also Figure S5. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Spontaneous DDR Signaling Is Consistent with Intermediate-State Telomeres at Senescence and Uncapped-State Telomeres at Crisis (A) Growth curves of IMR90, IMR90 E6E7, and WI-38 fibroblasts in hypoxic conditions used in (B–F). (B and C) Western blots of whole-cell extracts from IMR90 or WI-38 cultures with or without irradiation at the indicated population doublings. Irradiated cultures recovered for 1 hr before sample collection. (D) Quantitation of meta-TIF experiments shown in Figure S6. Asynchronous young or aged IMR90 cells were treated with 40 nM Hesperadin or DMSO and either 20 ng/ml colcemid for 2 hr or 100 ng/ml colcemid for 24 hr before sample preparation (mean ± SD; n = 3). (E) Cell-cycle profiles of young or aged IMR90 cultures following synchronization with a double thymidine block and release (a representative experiment of ≥15,000 cells per condition is shown). (F) Western blots of whole-cell extracts from IMR90 E6E7 cultures with or without irradiation at the indicated population doublings. Irradiated cultures recovered for 1 hr before sample collection. See also Figure S6. Molecular Cell 2013 51, 141-155DOI: (10.1016/j.molcel.2013.06.006) Copyright © 2013 Elsevier Inc. Terms and Conditions